Evidence map›Paper›PMID 23261843›Full record

ReviewAntiviral research2013

Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.

Lisa McLay, Aftab Ansari, Yuying Liang, Hinh Ly

Abstract readReview
In one paragraph

Review in Antiviral research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Assays to Assess Arenaviral Glycoprotein Function.Methods in molecular biology (Clifton, N.J.) · 2018
    Article
  9. Article
  10. Article
  11. Reverse Genetics Approaches to Control Arenavirus.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lisa McLayDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, United States.
Aftab Ansari
Yuying Liang
Hinh Ly
Emory University · USUniversity of Minnesota · US

Funding

Molecular determinants of virulent arenavirus infection in hostsR01AI083409 · NIAID · UNIVERSITY OF MINNESOTA · PI LIANG, YUYING · 2010 to 2014
$2.1M
Novel Mechanism of Immune Evasion by Arenaviral NucleoproteinsR01AI093580 · NIAID · UNIVERSITY OF MINNESOTA · PI LY, HINH · 2012 to 2016
$1.9M
Cap snatching mechanism of arenavirusesR56AI091805 · NIAID · UNIVERSITY OF MINNESOTA · PI LY, HINH · 2011 to 2011
$304k
NIAID NIH HHS AI083409NIAID NIH HHS R01 AI083409NIAID NIH HHS R01 AI093580NIAID NIH HHS R01AI093580NIAID NIH HHS R56 AI091805NIAID NIH HHS R56AI091805
6 · The paper itself

Abstract

A number of arenaviruses are pathogenic for humans, but they differ significantly in virulence. Lassa virus, found in West Africa, causes severe hemorrhagic fever (HF), while the other principal Old World arenavirus, lymphocytic choriomeningitis virus, causes mild illness in persons with normal immune function, and poses a threat only to immunocompromised individuals. The New World agents, including Junin, Machupo and Sabia virus, are highly pathogenic for humans. Arenaviral HF is characterized by high viremia and general immune suppression, the mechanism of which is unknown. Studies using viral reverse genetics, cell-based assays, animal models and human genome-wide association analysis have revealed potential mechanisms by which arenaviruses cause severe disease in humans. Each of the four viral gene products (GPC, L polymerase, NP, and Z matrix protein) and several host-cell factors (e.g., α-dystroglycan) are responsible for mediating viral entry, genome replication, and the inhibition of apoptosis, translation and interferon-beta (IFNβ) production. This review summarizes current knowledge of the role of each viral protein and host factor in the pathogenesis of arenaviral HF. Insights from recent studies are being exploited for the development of novel therapies.

Indexed as

Host-Pathogen InteractionsArenavirusHemorrhagic Fever, AmericanHumansViral ProteinsVirulence FactorsViral ProteinsVirulence Factors

Identifiers

PMID23261843
PMCPMC3563861
OpenAlexW2131993635

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.